Abiomed Reports Updated USpella Results at TCT 2010

September 23, 2010 |

1 min read

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced updated clinical data from USpella, a U.S. multicenter, observational registry of Impella 2.5® patients.

Events

MORE ON THIS TOPIC

Social media networking. Network with members connected with each other. Group of people. Communication, teamwork, community, society. Abstract concept with wooden pieces on blue background.

FDA

Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals

February 13, 2026

·

6 min read

·

Heather McKenzie

Viral vector, gene therapy, DNA delivery. Virus inserting genetic material into a cell nucleus. Gene editing, therapeutic genes, engineering, genetic diseases, dna, CRISPR, biotechnology. Medicine 3D illustration

Gene therapy

In Vivo Is Having a Moment as Cell and Gene Therapy Sector Gathers in San Diego

February 11, 2026

·

4 min read

·

Heather McKenzie

Sunset skyline of San Diego downtown viewed from Coronado Island.

gene therapy

Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity

January 28, 2026

·

4 min read

·

Heather McKenzie

Organizing Solutions and organizer concept as a Management leadership taking charge as a leader sorting out diverse ropes into an organized patterns as a business concept for strategy and control.

FDA

JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year

January 19, 2026

·

6 min read

·

Heather McKenzie